Variant report

Variant	nsv873899
Chromosome Location	chr2:40161168-40281964
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:434)
CpG islands
(count:244)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:434 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr2:40223765-40224372	K562	blood:	n/a	n/a
2	ATF1	chr2:40222613-40222712	K562	blood:	n/a	n/a
3	ATF1	chr2:40217162-40217725	K562	blood:	n/a	n/a
4	BACH1	chr2:40208471-40208655	H1-hESC	embryonic stem cell:	n/a	n/a
5	CBX3	chr2:40223784-40224393	HCT-116	colon:	n/a	n/a
6	CCNT2	chr2:40279953-40280153	K562	blood:	n/a	n/a
7	CCNT2	chr2:40224014-40224213	K562	blood:	n/a	n/a
8	CEBPB	chr2:40223752-40224243	IMR90	lung:	n/a	n/a
9	CEBPB	chr2:40221391-40221660	IMR90	lung:	n/a	n/a
10	CEBPB	chr2:40187059-40187300	IMR90	lung:	n/a	n/a
11	CEBPB	chr2:40223679-40224438	HCT-116	colon:	n/a	n/a
12	CEBPB	chr2:40223865-40224375	HCT-116	colon:	n/a	n/a
13	CEBPB	chr2:40187092-40187228	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr2:40259963-40260548	IMR90	lung:	n/a	n/a
15	CEBPB	chr2:40258067-40258360	K562	blood:	n/a	chr2:40258206-40258217
16	CEBPB	chr2:40258064-40258380	A549	lung:	n/a	chr2:40258206-40258217
17	CEBPB	chr2:40194850-40195177	HepG2	liver:	n/a	chr2:40195008-40195019
18	CEBPB	chr2:40269113-40269506	IMR90	lung:	n/a	n/a
19	CEBPB	chr2:40258041-40258398	IMR90	lung:	n/a	chr2:40258206-40258217
20	CEBPB	chr2:40218557-40218771	H1-hESC	embryonic stem cell:	n/a	chr2:40218674-40218685
21	CEBPB	chr2:40194909-40195167	H1-hESC	embryonic stem cell:	n/a	chr2:40195008-40195019
22	CEBPB	chr2:40223962-40224177	A549	lung:	n/a	n/a
23	CEBPB	chr2:40218494-40218859	IMR90	lung:	n/a	chr2:40218674-40218685
24	CEBPB	chr2:40243703-40243880	A549	lung:	n/a	chr2:40243790-40243803 chr2:40243792-40243803
25	CEBPB	chr2:40258083-40258389	HepG2	liver:	n/a	chr2:40258206-40258217
26	CEBPB	chr2:40266300-40266894	IMR90	lung:	n/a	n/a
27	CEBPB	chr2:40243495-40243987	IMR90	lung:	n/a	chr2:40243790-40243803 chr2:40243792-40243803
28	CEBPB	chr2:40194970-40195037	K562	blood:	n/a	chr2:40195008-40195019
29	CEBPB	chr2:40218529-40218785	HepG2	liver:	n/a	chr2:40218674-40218685
30	CEBPB	chr2:40218547-40218785	A549	lung:	n/a	chr2:40218674-40218685
31	CEBPB	chr2:40223859-40224267	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr2:40194890-40195200	A549	lung:	n/a	chr2:40195008-40195019
33	CHD2	chr2:40223919-40224266	Hela-S3	cervix:	n/a	n/a
34	CTCF	chr2:40191169-40191216	H1-hESC	embryonic stem cell:	n/a	n/a
35	CTCF	chr2:40191040-40191190	WERI-Rb-1	eye:	n/a	n/a
36	CTCF	chr2:40191020-40191170	RPTEC	kidney:	n/a	n/a
37	CTCF	chr2:40190220-40190370	Hela-S3	cervix:	n/a	n/a
38	CTCF	chr2:40191000-40191150	HAc	cerebellar:	n/a	n/a
39	CTCF	chr2:40191167-40191213	MCF-7	breast:	n/a	n/a
40	CTCF	chr2:40190252-40190334	H1-hESC	embryonic stem cell:	n/a	n/a
41	CTCF	chr2:40216640-40216790	HRE	kidney:	n/a	n/a
42	CTCF	chr2:40216520-40216670	HMEC	breast:	n/a	n/a
43	CTCF	chr2:40191103-40191247	MCF-7	breast:	n/a	n/a
44	CTCF	chr2:40190320-40190470	HCFaa	heart:	n/a	n/a
45	CTCF	chr2:40235360-40235510	MCF-7	breast:	n/a	n/a
46	CTCF	chr2:40235320-40235470	HCT-116	colon:	n/a	n/a
47	CTCF	chr2:40190420-40190570	GM12875	blood:	n/a	n/a
48	CTCF	chr2:40273874-40273939	GM13976	blood:	n/a	n/a
49	CTCF	chr2:40221517-40221568	GM10248	blood:	n/a	n/a
50	CTCF	chr2:40228397-40228552	K562	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:40266366-40266416	Jurkat	blood:	n/a
2	chr2:40260498-40260548	GM12878	blood:	n/a
3	chr2:40165558-40165608	RPTEC	kidney:	n/a
4	chr2:40260498-40260548	SK-N-SH_RA	brain:	n/a
5	chr2:40203342-40203392	HepG2	liver:	n/a
6	chr2:40165558-40165608	LNCaP	prostate:	n/a
7	chr2:40260498-40260548	HAEpiC	amniotic membrane:	n/a
8	chr2:40260498-40260548	AG09319	gingival:	n/a
9	chr2:40266366-40266416	PFSK-1	brain:	n/a
10	chr2:40260498-40260548	HCPEpiC	choroid plexus:	n/a
11	chr2:40203342-40203392	IMR90	lung:	fetal
12	chr2:40266366-40266416	HRE	kidney:	n/a
13	chr2:40266366-40266416	HRPEpiC	eye:	n/a
14	chr2:40266366-40266416	NHBE	bronchial:	n/a
15	chr2:40165558-40165608	AoSMC	blood vessel:	n/a
16	chr2:40266366-40266416	HCF	heart:	n/a
17	chr2:40266366-40266416	ECC-1	luminal epithelium:	n/a
18	chr2:40260498-40260548	HRCEpiC	kidney:	n/a
19	chr2:40203342-40203392	SKMC	muscle:	n/a
20	chr2:40203342-40203392	U87	brain:	n/a
21	chr2:40260498-40260548	BJ	skin:	n/a
22	chr2:40165558-40165608	AG09319	gingival:	n/a
23	chr2:40260498-40260548	AG09309	skin:	n/a
24	chr2:40165558-40165608	MCF-7	breast:	n/a
25	chr2:40165558-40165608	GM12892	blood:	n/a
26	chr2:40260498-40260548	LNCaP	prostate:	n/a
27	chr2:40165558-40165608	HMEC	breast:	n/a
28	chr2:40203342-40203392	HL-60	blood:	n/a
29	chr2:40260498-40260548	AG10803	skin:	n/a
30	chr2:40203342-40203392	H1-hESC	embryonic stem cell:	embryo
31	chr2:40203342-40203392	SK-N-SH_RA	brain:	n/a
32	chr2:40266366-40266416	GM12878	blood:	n/a
33	chr2:40266366-40266416	HCT-116	colon:	n/a
34	chr2:40203342-40203392	HRE	kidney:	n/a
35	chr2:40260498-40260548	AoSMC	blood vessel:	n/a
36	chr2:40260498-40260548	PFSK-1	brain:	n/a
37	chr2:40266366-40266416	HRCEpiC	kidney:	n/a
38	chr2:40165558-40165608	T-47D	breast:	n/a
39	chr2:40203342-40203392	SK-N-SH	brain:	n/a
40	chr2:40266366-40266416	SK-N-SH	brain:	n/a
41	chr2:40266366-40266416	SKMC	muscle:	n/a
42	chr2:40266366-40266416	HCPEpiC	choroid plexus:	n/a
43	chr2:40165558-40165608	HCF	heart:	n/a
44	chr2:40203342-40203392	LNCaP	prostate:	n/a
45	chr2:40260498-40260548	NB4	blood:	n/a
46	chr2:40165558-40165608	U87	brain:	n/a
47	chr2:40165558-40165608	HPAEpiC	pulmonary alveolar:	n/a
48	chr2:40165558-40165608	HCM	heart:	n/a
49	chr2:40203342-40203392	NHDF-neo	bronchial:	n/a
50	chr2:40266366-40266416	AG04449	skin:	fetal

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:
2	chr2:40164512..40166990-chr2:40173493..40175018,2	MCF-7	breast:
3	chr2:40254887..40256636-chr2:40272268..40275019,2	K562	blood:
4	chr2:40248216..40251072-chr2:40272085..40274359,2	K562	blood:
5	chr2:40164512..40166990-chr2:40173493..40175018,2	MCF-7	breast:
6	chr2:40248216..40251072-chr2:40272085..40274359,2	K562	blood:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TMEM178-2	chr2:40269490-40269613	ENSG00000227028.1
2	lnc-TMEM178-2	chr2:40185553-40185606	ucscGeneNc_uc002rrw_2
3	lnc-TMEM178-2	chr2:40270558-40270682	ENSG00000227028.1

No data

Variant related genes	Relation type
SLC8A1-AS1	TF binding region
SLC8A1-AS1	CpG island

Extended variants
information (count: 6856 )
Associated
traits (count: 63 )

Variant overlapped rSNPs/rCNVs (count:6856 , 50 per page) page: 1 2 3 4 5 6 7 ... 138

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1861260	chr2:40161168-40161169	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs552292034	chr2:40161233-40161234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs574043431	chr2:40161260-40161261	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs117888977	chr2:40161285-40161286	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs559567028	chr2:40161375-40161376	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs577947172	chr2:40161383-40161384	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs545240870	chr2:40161403-40161404	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs200061465	chr2:40161406-40161407	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs563546664	chr2:40161444-40161445	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs534689964	chr2:40161512-40161513	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs185211854	chr2:40161522-40161523	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs370538617	chr2:40161527-40161528	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs76165021	chr2:40161565-40161566	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs117264556	chr2:40161566-40161567	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs528169865	chr2:40161591-40161592	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs546700572	chr2:40161593-40161594	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs190026452	chr2:40161609-40161610	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs145342664	chr2:40161644-40161645	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs551565476	chr2:40161718-40161719	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs569978314	chr2:40161725-40161726	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs537790804	chr2:40161746-40161747	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs182701403	chr2:40161759-40161760	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs535362583	chr2:40161765-40161766	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs555476430	chr2:40161770-40161771	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs567680258	chr2:40161771-40161772	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs147678107	chr2:40161773-40161774	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs574562943	chr2:40161781-40161782	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs77793333	chr2:40161855-40161856	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs557489087	chr2:40161909-40161910	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs575848735	chr2:40161944-40161945	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs546520470	chr2:40161975-40161976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs374095478	chr2:40161979-40161980	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs145306081	chr2:40161986-40161987	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs564613097	chr2:40161996-40161997	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs142430655	chr2:40162037-40162038	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs112511221	chr2:40162041-40162042	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs578159490	chr2:40162045-40162046	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs545177497	chr2:40162078-40162079	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs186716845	chr2:40162081-40162082	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs191923703	chr2:40162086-40162087	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs542954653	chr2:40162116-40162117	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs201466802	chr2:40162147-40162148	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs560697414	chr2:40162179-40162180	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs528121487	chr2:40162193-40162194	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs539861102	chr2:40162200-40162201	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs183660082	chr2:40162204-40162205	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs12468298	chr2:40162245-40162246	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
48	rs551553836	chr2:40162250-40162251	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs58460675	chr2:40162265-40162266	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
50	rs76176884	chr2:40162274-40162275	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:63)

Disease	PMID	Source
Breast cancer	17393978	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
lymphocytic leukemia	21291569	CNVD
Prostate cancer	18632612	CNVD
Bladder cancer	21909424	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Leukemia	18628472	CNVD
Autism	22495311	CNVD
Autism	19521722	CNVD
Autism	18522746	CNVD
Non-small cell lung cancer	18927303	CNVD
Breast cancer	21785460	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	21965145	CNVD
Breast cancer	16397240	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21508638	CNVD
Neurodevelopmental disorder	22521361	CNVD
Neurocytoma	17123091	CNVD
small cell lung cancer	20016488	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Breast cancer	22522925	CNVD
Williams Syndrome	20824207	CNVD
T-cell lymphomas	22341440	CNVD
Pancreatic cancer	17952125	CNVD
Schizophrenia	23813976	CNVD

Chromatin state (count:456 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:40141600-40164800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
2	chr2:40147000-40167400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr2:40158800-40164800	Weak transcription	Fetal Thymus	thymus
4	chr2:40159200-40164800	Weak transcription	HSMM	muscle
5	chr2:40159400-40165000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr2:40159600-40162000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr2:40160000-40161200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
8	chr2:40160200-40164600	Enhancers	Dnd41	blood
9	chr2:40160400-40161200	Weak transcription	Fetal Stomach	stomach
10	chr2:40160600-40164800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
11	chr2:40161200-40161400	Enhancers	Fetal Stomach	stomach
12	chr2:40161200-40165000	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
13	chr2:40162000-40162600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr2:40164600-40166400	Flanking Active TSS	Dnd41	blood
15	chr2:40164800-40165000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
16	chr2:40164800-40166000	Enhancers	Primary hematopoietic stem cells short term culture	blood
17	chr2:40164800-40166200	Enhancers	Fetal Thymus	thymus
18	chr2:40164800-40166400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
19	chr2:40164800-40166400	Enhancers	HSMM	muscle
20	chr2:40164800-40166400	Enhancers	Osteobl	bone
21	chr2:40165000-40165600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr2:40165000-40166400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
23	chr2:40165000-40166600	Enhancers	Muscle Satellite Cultured Cells	--
24	chr2:40165000-40166600	Enhancers	NH-A	brain
25	chr2:40165000-40166800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
26	chr2:40165000-40175800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
27	chr2:40165200-40165600	Enhancers	HSMMtube	muscle
28	chr2:40165200-40166000	Enhancers	ES-I3 Cell Line	embryonic stem cell
29	chr2:40165200-40166400	Enhancers	HUES64 Cell Line	embryonic stem cell
30	chr2:40165200-40166400	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
31	chr2:40165400-40165800	Enhancers	Thymus	Thymus
32	chr2:40165400-40166400	Enhancers	HMEC	breast
33	chr2:40165600-40169400	Weak transcription	HSMMtube	muscle
34	chr2:40165600-40175200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
35	chr2:40166400-40168200	Enhancers	Dnd41	blood
36	chr2:40166400-40169400	Weak transcription	HSMM	muscle
37	chr2:40166400-40169800	Weak transcription	Osteobl	bone
38	chr2:40166600-40169600	Weak transcription	NH-A	brain
39	chr2:40166600-40170000	Weak transcription	Muscle Satellite Cultured Cells	--
40	chr2:40166800-40167200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr2:40166800-40168400	Weak transcription	Fetal Thymus	thymus
42	chr2:40167200-40167400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr2:40167400-40167600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
44	chr2:40167400-40170200	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr2:40167600-40167800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
46	chr2:40169400-40170600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr2:40169400-40170600	Enhancers	Dnd41	blood
48	chr2:40169400-40170600	Enhancers	HSMM	muscle
49	chr2:40169400-40170600	Enhancers	HSMMtube	muscle
50	chr2:40169400-40170800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links